Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase

Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase
Ebos CEO John Cullity doesn't want to pre-empt regulators. (Image: supplied)
Jenny Ruth
Ebos Group's purchase of the LifeHealthcare business is unlikely to have trouble clearing competition watchdogs on either side of the Tasman since its existing medical devices business is quite small.Ebos bought the LMT and National Surgical businesses in late 2019 for A$34 million compared with the LifeHealthcare purchase price of A$1.17 billion.In August last year, it also announced the purchase of Pioneer Medical, a New Zealand-based importer and distributor of spine and major joint implants and associated surgical technologies.Ebos didn...

More Infrastructure

Infrastructure Plan floats higher health, electricity spend
Policy

Infrastructure Plan floats higher health, electricity spend

Draft plan identifies priority projects and recommends transport system reform.

Chorus broadband expansion makes priority list
Infrastructure

Chorus broadband expansion makes priority list

Chorus claims $17 billion NZ Inc gain for a $3b spend.

Infrastructure plan: 17 projects made it, 31 missed out
Policy

Infrastructure plan: 17 projects made it, 31 missed out

Rail, prison and ferry terminal projects excluded from infrastructure priority list.

Fletcher's restructuring, impairment costs could hit $781m
Infrastructure

Fletcher's restructuring, impairment costs could hit $781m

It expects ebit of $370m to $375m before significant items. 

Rebecca Howard 24 Jun 2025